Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014

Cancer Vaccines

15 Sep 2014 - 16 Sep 2014 - London, UK

Bookmark and Share

Quantify Strategies to Enhance Cancer Vaccine Research and Development

The global therapeutic cancer vaccines market is expected to grow to a value of $7.8 billion by 2019. As companies look to develop new drugs to enter this rapidly growing industry, Cancer Vaccines 2014 will mark the path forward in terms of cancer vaccine research, clinical development and regulation.

SMi Group have worked closely with an expert speaker panel which includes KOLs from Amal Therapeutics, Amgen, DanDrit Biotech, CureVac and Vaccinogen, to put together an exciting conference agenda for the 3rd annual conference taking place on 15th and 16th September in London UK.

This year's programme will feature a mix of case study led presentations, networking opportunities, an interactive workshop and keynote addresses that have been tailored for an audience of professionals working in the cancer vaccine market from drug design through to clinical trials and treatment.

Previous Testimonials Include:

"Great focused meeting. Good range of speakers and topics" – INSERM

"I found the conference very informative and the standard of the presentations was very good. I’m pleased that I attended" - Asterand

Key Speakers Include:

Joseph Melenhorst, Director of the Product Development & Correlative Sciences Laboratory, University Of Pennsylvania

Tom Lillie, Therapeutic Area Head, Oncology, Amgen Ltd

Alex Karlsson-Parra, CSO, Immunicum AB

Birgit Scheel, Director Program Management Oncology, Curevac GmbH

Harpreet Singh, Managing Director, Founder and CSO, Immatics Biotechnologies GmbH

Christian Ottensmeier, Professor in Experimental Cancer Medicine, University Of Southampton

Madiha Derouazi, CEO, Amal Therapeutics

Eric Leire, CEO, DanDrit Biotech

Why Attend in 2014?

Insight into a Perfect Partnership – University of Pennsylvania and Novartis Collaboration! Hear it here first: Assessing techniques involved in removing a patient's T cells and inserting new genetic material to enable the T cells to attack and kill cancer cells

Assessing Oncolytic Vaccines - Reviewing developments from Amgen and Psioxus Therapeutics

What are the key questions in Cancer Immunotherapy? Professor Christian Ottensmeier attacks this question head on!

Evaluating analytical advances for Cancer Vaccines with an insight from Key Opinion Leaders at Immatics GmbH, Vaccinogen and the University of Southampton

To register or download a brochure visit: 

For further details, contact Sajid Goraya on +44 (0)20 7827 6148 or email 

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos